Additional Information
Book Details
Abstract
The only book of its kind, Manual of High Risk Pregnancy & Delivery provides a complete resource for care of this special patient and her complex needs. It helps you provide positive outcomes with coverage of today's newest technology, physiologic considerations, psychologic implications, health disorders, and other complications in pregnancy. Written by noted educator and practitioner Elizabeth Stepp Gilbert, RNC, MS, FNP-BC, CNS, this book also describes how to screen for risk factors, provide preventive management, and intervene appropriately when problems arise. It's a concise, hands-on reference for both inpatient and outpatient settings!
- A consistent format makes this book a practical, hands-on reference in the clinical setting, presenting problems with the following headings: incidence, etiology, physiology, pathophysiology, and medical management.
- Comprehensive coverage includes physiologic considerations, fetal assessment, perinatal screening, ethical and legal issues, health disorders during pregnancy, complications, and labor and delivery issues.
- Up-to-date content includes integrative therapy, domestic violence, multiple gestation, genetics, nutrition, culture, risk management, and all the latest screening tools.
- A section on ethical and legal considerations covers ethical decision making, legal issues, and risk management.
- Updated evidence-based content includes the latest AHWONN standards of practice.
- Patient safety and risk management strategies include updated approaches to improving outcomes, reducing complications, and increasing patient safety during high risk pregnancy and delivery.
- New Venous Thromboembolic Disease chapter provides current information on this increasingly common condition.
- Information on the latest assessment and monitoring devices keeps you current with today's technology.
- Standardized terminology and definitions from the National Institute of Child Health & Human Development (NICHD) lead to accurate and precise communication.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover\r | Cover | ||
| Manual of High Risk Pregnancy & Delivery\r | i | ||
| Copyright\r | ii | ||
| Dedication\r | iii | ||
| Contributors | iv | ||
| Preface | v | ||
| Contents | vii | ||
| UNIT ONE PHYSIOLOGIC CONSIDERATIONS, ASSESSMENTS,\rAND INTEGRATIVE THERAPIES | 1 | ||
| Chapter 1\rPhysiologic and Nutritional Adaptations to Pregnancy | 1 | ||
| ADAPTATIONS | 1 | ||
| DEVELOPMENT OF THE MATERNAL-FETAL UNIT | 4 | ||
| EXERCISE AND BEDREST | 6 | ||
| ANTEPARTUM NUTRITION | 10 | ||
| CONCLUSION | 21 | ||
| Chapter 2 General Nursing Assessment of the High Risk Expectant Family | 25 | ||
| ANTEPARTUM NURSING ASSESSMENT | 25 | ||
| ANTEPARTUM DIAGNOSTIC ASSESSMENT | 26 | ||
| ANTEPARTUM PHYSICAL ASSESSMENT | 36 | ||
| HIGH RISK FACTORS | 37 | ||
| CONCLUSION | 41 | ||
| Chapter 3\rAssessment of Fetal Well-Being | 43 | ||
| PHYSIOLOGY AND PATHOPHYSIOLOGY OF FETAL OXYGENATION | 43 | ||
| UTEROPLACENTAL-FETAL EXCHANGE\x04 | 44 | ||
| PHYSIOLOGIC BASIS OF FETAL HEART RATE CONTROL | 46 | ||
| FETAL HEART RATE MONITORING | 46 | ||
| ANTEPARTUM AND INTRAPARTUM FETAL SURVEILLANCE | 65 | ||
| NURSING MANAGEMENT | 83 | ||
| CONCLUSION | 84 | ||
| Chapter 4\rPerinatal Screening, Diagnoses, and Fetal Therapies | 88 | ||
| PRENATAL GENETIC SCREENING | 88 | ||
| SCREENING METHODS | 89 | ||
| ULTRASOUND EVALUATION FOR FETAL ABNORMALITIES | 91 | ||
| PRENATAL DIAGNOSTIC TESTS | 92 | ||
| OTHER INVASIVE DIAGNOSTIC FETAL \nPROCEDURES | 97 | ||
| PRENATAL THERAPY | 101 | ||
| NURSING MANAGEMENT | 104 | ||
| CONCLUSION | 105 | ||
| Chapter 5\rIntegrative Therapies in Pregnancy and Childbirth | 107 | ||
| BRIEF OVERVIEW OF SELECTED INTEGRATIVE THERAPIES IN PREGNANCY | 108 | ||
| MANAGEMENT OF ALTERNATIVE AND COMPLEMENTARY THERAPIES IN PREGNANCY | 116 | ||
| CONCLUSION | 126 | ||
| UNIT TWO\rPSYCHOLOGIC IMPLICATIONS OF A HIGH RISK PREGNANCY | 128 | ||
| Chapter 6\rPsychologic Adaptations | 128 | ||
| ATTACHMENT | 128 | ||
| MATERNAL TASKS | 130 | ||
| PATERNAL TASKS | 130 | ||
| HIGH RISK STRESSORS | 131 | ||
| PSYCHOLOGIC RESPONSES TO A HIGH RISK PREGNANCY | 132 | ||
| HORMONAL RESPONSE TO A HIGH RISK PREGNANCY | 133 | ||
| HIGH RISK ADAPTATION | 133 | ||
| NURSING MANAGEMENT DURING A HIGH RISK PREGNANCY | 134 | ||
| PRENATAL DEPRESSION | 138 | ||
| POSTPARTUM DEPRESSION | 138 | ||
| USUAL MEDICAL MANAGEMENT AND PROTOCOLS FOR NURSE PRACTITIONERS | 140 | ||
| TREATMENT OF PRENATAL AND POSTPARTUM DEPRESSION | 143 | ||
| CONCLUSION | 145 | ||
| Chapter 7 Perinatal Death and \r\rBereavement Care | 149 | ||
| BRIEF HISTORY OF PERINATAL BEREAVEMENT CARE | 149 | ||
| CONTINUING DEVELOPMENT \nOF BEREAVEMENT CARE | 151 | ||
| CONTACT WITH THE BABY’S BODY | 153 | ||
| SUPPORT DURING SUBSEQUENT PREGNANCY | 153 | ||
| CUTTING-EDGE TOPICS IN PERINATAL BEREAVEMENT CARE | 163 | ||
| CONCLUSION | 165 | ||
| UNIT THREE ETHICAL DILEMMAS AND LEGAL CONSIDERATIONS\rIN PERINATAL NURSING\r | 170 | ||
| Chapter 8 Ethical Decision Making\r | 170 | ||
| VALUES CLARIFICATION | 170 | ||
| MORAL JUDGMENT DEVELOPMENT | 171 | ||
| FRAMEWORK FOR ETHICS | 173 | ||
| MODEL FOR ETHICAL DECISION MAKING | 173 | ||
| PATIENT SELF-DETERMINATION ACT | 176 | ||
| ADVANCE DIRECTIVE | 177 | ||
| ETHICS COMMITTEE | 178 | ||
| CLINICAL EXAMPLES OF ETHICAL DILEMMAS | 178 | ||
| CONCLUSION | 178 | ||
| Chapter 9\rLegal Issues and Risk Management | 181 | ||
| MALPRACTICE INSURANCE | 181 | ||
| REASONS PARENTS SUE | 182 | ||
| LITIGATION RISK | 183 | ||
| MID-LEVEL PROVIDERS | 185 | ||
| EFFECT OF INCREASED LITIGATION ON HEALTH CARE | 186 | ||
| SYSTEMS OF LAW | 186 | ||
| LITIGATION SEQUENCE | 187 | ||
| NURSE’S DEPOSITION | 190 | ||
| TRIAL | 191 | ||
| PERINATAL SAFETY NURSE | 196 | ||
| EXPERT WITNESS | 197 | ||
| CONCLUSION | 197 | ||
| UNIT FOUR\rHEALTH DISORDERS COMPLICATING PREGNANCY | 200 | ||
| Chapter 10\rDiabetes | 200 | ||
| INCIDENCE | 201 | ||
| CAUSES | 202 | ||
| NORMAL PHYSIOLOGY | 202 | ||
| PATHOPHYSIOLOGY | 203 | ||
| SIGNS AND SYMPTOMS | 204 | ||
| MATERNAL EFFECTS | 204 | ||
| FETAL AND NEONATAL EFFECTS | 207 | ||
| DIAGNOSTIC TESTING | 210 | ||
| USUAL MEDICAL MANAGEMENT AND PROTOCOLS FOR NURSE PRACTITIONERS | 212 | ||
| NURSING MANAGEMENT | 223 | ||
| CONCLUSION | 238 | ||
| BIBLIOGRAPHY | 240 | ||
| Chapter 11\rCardiac Disease | 243 | ||
| INCIDENCE | 243 | ||
| ETIOLOGY | 243 | ||
| NORMAL PHYSIOLOGY | 244 | ||
| MATERNAL EFFECTS | 247 | ||
| FETAL AND NEONATAL EFFECTS | 248 | ||
| DIAGNOSTIC TESTING | 248 | ||
| USUAL MEDICAL MANAGEMENT AND PROTOCOLS FOR NURSE PRACTITIONERS | 248 | ||
| NURSING MANAGEMENT | 251 | ||
| CONCLUSION | 256 | ||
| Chapter 12\rRenal Disease | 258 | ||
| INCIDENCE | 258 | ||
| ETIOLOGY | 259 | ||
| NORMAL PHYSIOLOGY | 259 | ||
| SIGNS AND SYMPTOMS | 261 | ||
| MATERNAL EFFECTS | 263 | ||
| FETAL AND NEONATAL EFFECTS | 263 | ||
| DIAGNOSTIC TESTING | 263 | ||
| USUAL MEDICAL MANAGEMENT AND PROTOCOLS FOR NURSE PRACTITIONERS | 265 | ||
| NURSING MANAGEMENT | 267 | ||
| CONCLUSION | 269 | ||
| BIBLIOGRAPHY | 270 | ||
| Chapter 13\rAutoimmune Rheumatic Diseases | 271 | ||
| INCIDENCE | 271 | ||
| ETIOLOGY | 272 | ||
| NORMAL PHYSIOLOGY | 272 | ||
| PATHOPHYSIOLOGY | 272 | ||
| SIGNS AND SYMPTOMS | 272 | ||
| MATERNAL EFFECTS | 274 | ||
| FETAL AND NEONATAL EFFECTS | 274 | ||
| MEDICAL DIAGNOSIS | 275 | ||
| USUAL MEDICAL MANAGEMENT AND PROTOCOLS FOR NURSE PRACTITIONERS | 276 | ||
| NURSING MANAGEMENT | 277 | ||
| CONCLUSION | 280 | ||
| BIBLIOGRAPHY | 281 | ||
| Chapter 14\rVenous Thromboembolic Disease | 282 | ||
| INCIDENCE | 282 | ||
| ETIOLOGY | 282 | ||
| NORMAL PHYSIOLOGY | 283 | ||
| SIGNS AND SYMPTOMS | 283 | ||
| MATERNAL EFFECTS | 283 | ||
| FETAL AND NEONATAL EFFECTS | 283 | ||
| DIAGNOSTIC TESTING | 283 | ||
| USUAL MEDICAL MANAGEMENT AND PROTOCOLS FOR NURSE PRACTITIONERS | 284 | ||
| NURSING MANAGEMENT | 286 | ||
| CONCLUSION | 287 | ||
| BIBLIOGRAPHY | 287 | ||
| Chapter 15\rPulmonary Disease and Respiratory\rDistress | 289 | ||
| INCIDENCE | 289 | ||
| ETIOLOGY | 290 | ||
| NORMAL PHYSIOLOGY | 291 | ||
| PATHOPHYSIOLOGY | 292 | ||
| SIGNS AND SYMPTOMS | 292 | ||
| MATERNAL EFFECTS | 293 | ||
| FETAL EFFECTS | 294 | ||
| DIAGNOSTIC TESTING | 295 | ||
| USUAL MEDICAL MANAGEMENT AND PROTOCOLS FOR NURSE PRACTITIONERS | 297 | ||
| NURSING MANAGEMENT | 303 | ||
| CONCLUSION | 309 | ||
| BIBLIOGRAPHY | 309 | ||
| UNIT FIVE\rCOMPLICATIONS IN PREGNANCY | 311 | ||
| Chapter 16\rSpontaneous Abortion | 311 | ||
| INCIDENCE | 311 | ||
| ETIOLOGY | 311 | ||
| NORMAL PHYSIOLOGY | 313 | ||
| PATHOPHYSIOLOGY | 315 | ||
| SIGNS AND SYMPTOMS | 315 | ||
| CLASSIFICATION | 316 | ||
| MATERNAL EFFECTS | 316 | ||
| FETAL EFFECTS | 317 | ||
| DIAGNOSTIC TESTING | 317 | ||
| USUAL MEDICAL MANAGEMENT AND PROTOCOLS FOR NURSE PRACTITIONERS | 318 | ||
| NURSING MANAGEMENT | 325 | ||
| CONCLUSION | 328 | ||
| Chapter 17\rEctopic Pregnancy | 331 | ||
| INCIDENCE | 331 | ||
| ETIOLOGY | 331 | ||
| NORMAL PHYSIOLOGY | 333 | ||
| PATHOPHYSIOLOGY | 333 | ||
| SIGNS AND SYMPTOMS | 336 | ||
| MATERNAL EFFECTS | 337 | ||
| FETAL AND NEONATAL EFFECTS | 337 | ||
| DIAGNOSTIC TESTING | 337 | ||
| USUAL MEDICAL MANAGEMENT | 344 | ||
| NURSING MANAGEMENT | 346 | ||
| CONCLUSION | 349 | ||
| Chapter18\rGestational Trophoblastic Disease | 351 | ||
| HYDATIDIFORM MOLE | 351 | ||
| GESTATIONAL TROPHOBLASTIC NEOPLASIA | 356 | ||
| NURSING MANAGEMENT | 360 | ||
| CONCLUSION | 362 | ||
| Chapter 19\rPlacental Abnormalities | 364 | ||
| ABRUPTIO PLACENTAE | 364 | ||
| PLACENTA PREVIA | 376 | ||
| INVASIVE PLACENTA (PLACENTA CRETAS) | 381 | ||
| VASA PREVIA | 385 | ||
| NURSING MANAGEMENT | 386 | ||
| CONCLUSION | 393 | ||
| Chapter 20\rDisseminated Intravascular Coagulation | 395 | ||
| INCIDENCE | 395 | ||
| ETIOLOGY | 395 | ||
| NORMAL PHYSIOLOGY | 396 | ||
| PATHOPHYSIOLOGY | 397 | ||
| SIGNS AND SYMPTOMS | 398 | ||
| MATERNAL EFFECTS | 398 | ||
| FETAL AND NEONATAL EFFECTS | 398 | ||
| DIAGNOSTIC TESTING | 399 | ||
| USUAL MEDICAL MANAGEMENT AND PROTOCOLS FOR NURSE PRACTITIONERS | 399 | ||
| NURSING MANAGEMENT | 400 | ||
| CONCLUSION | 401 | ||
| Chapter 21\rHemolytic Incompatibility | 402 | ||
| INCIDENCE | 402 | ||
| ETIOLOGY | 402 | ||
| NORMAL PHYSIOLOGY | 402 | ||
| PATHOPHYSIOLOGY | 406 | ||
| SIGNS AND SYMPTOMS | 406 | ||
| MATERNAL EFFECTS | 407 | ||
| FETAL AND NEONATAL EFFECTS | 407 | ||
| DIAGNOSTIC TESTING | 408 | ||
| USUAL MEDICAL MANAGEMENT AND PROTOCOLS FOR NURSE PRACTITIONERS | 409 | ||
| NURSING MANAGEMENT | 412 | ||
| CONCLUSION | 414 | ||
| Chapter 22\rHypertensive Disorders | 416 | ||
| INCIDENCE | 417 | ||
| CHRONIC HYPERTENSION | 418 | ||
| PREECLAMPSIA | 420 | ||
| USUAL MEDICAL MANAGEMENT AND PROTOCOLS FOR NURSE PRACTITIONERS | 431 | ||
| NURSING MANAGEMENT | 434 | ||
| CONCLUSION | 454 | ||
| Chapter 23\rPreterm Labor and Multiple Gestation | 460 | ||
| PRETERM LABOR | 460 | ||
| MULTIPLE GESTATION | 460 | ||
| INCIDENCE | 460 | ||
| ETIOLOGY | 461 | ||
| NORMAL ANATOMY OF THE CERVIX | 461 | ||
| NORMAL PHYSIOLOGY OF LABOR CONTRACTIONS | 461 | ||
| PROSTAGLANDINS | 463 | ||
| NORMAL PHYSIOLOGIC ADAPTATION OF MULTIPLE GESTATION | 464 | ||
| PATHOPHYSIOLOGY | 464 | ||
| MATERNAL EFFECTS | 465 | ||
| FETAL AND NEONATAL EFFECTS | 465 | ||
| NATIONAL EFFECTS | 468 | ||
| DIAGNOSTIC TESTING | 468 | ||
| USUAL MEDICAL MANAGEMENT AND PROTOCOLS FOR NURSE PRACTITIONERS: | 470 | ||
| PRIMARY PREVENTION | 470 | ||
| SECONDARY PREVENTION | 471 | ||
| NURSING MANAGEMENT | 474 | ||
| CONCLUSION | 482 | ||
| Chapter 24\rPremature Rupture of Membranes | 488 | ||
| INCIDENCE | 488 | ||
| ETIOLOGY | 488 | ||
| NORMAL PHYSIOLOGY | 489 | ||
| PATHOPHYSIOLOGY | 489 | ||
| MATERNAL EFFECTS | 490 | ||
| FETAL AND NEONATAL EFFECTS | 490 | ||
| DIAGNOSTIC TESTING | 491 | ||
| USUAL MEDICAL MANAGEMENT AND PROTOCOLS F | 492 | ||
| NURSING MANAGEMENT | 495 | ||
| CONCLUSION | 498 | ||
| Chapter 25\rTrauma | 500 | ||
| INCIDENCE | 500 | ||
| ETIOLOGY | 500 | ||
| PATHOPHYSIOLOGY | 501 | ||
| HEMORRHAGE | 501 | ||
| MATERNAL EFFECTS | 504 | ||
| FETAL EFFECTS | 504 | ||
| MANAGEMENT OF THE PREGNANT TRAUMA PATIENT | 505 | ||
| NURSING MANAGEMENT | 508 | ||
| CONCLUSION | 516 | ||
| BIBLIOGRAPHY | 517 | ||
| UNIT SIX\rTERATOGENS AND SOCIAL ISSUES COMPLICATING PREGNANCY | 519 | ||
| Chapter 26\rSexually and Nonsexually Transmitted Genitourinary Infections | 519 | ||
| BACTERIAL VAGINOSIS | 519 | ||
| CANDIDIASIS | 521 | ||
| CHLAMYDIA | 522 | ||
| GONORRHEA | 524 | ||
| GROUP B STREPTOCOCCUS INFECTION | 525 | ||
| HEPATITIS B | 527 | ||
| HEPATITIS C | 530 | ||
| HERPES SIMPLEX VIRUS TYPE 2 | 531 | ||
| HUMAN IMMUNODEFICIENCY VIRUS | 533 | ||
| HUMAN PAPILLOMAVIRUS | 539 | ||
| HUMAN PARVOVIRUS B19 | 542 | ||
| SYPHILIS | 543 | ||
| TRICHOMONIASIS | 545 | ||
| URINARY TRACT INFECTION | 546 | ||
| GENERAL NURSING MANAGEMENT FOR GENITOURINARY INFECTIONS | 549 | ||
| CONCLUSION | 551 | ||
| Chapter 27\rSubstance Abuse | 558 | ||
| ALCOHOL | 558 | ||
| COCAINE | 564 | ||
| HEROIN | 567 | ||
| MARIJUANA | 569 | ||
| METHAMPHETAMINES | 570 | ||
| TOBACCO | 571 | ||
| NURSING MANAGEMENT | 574 | ||
| CONCLUSION | 575 | ||
| UNIT SEVEN\rALTERATIONS IN THE MECHANISM OF LABOR | 582 | ||
| Chapter 28\rLabor Stimulation | 582 | ||
| INCIDENCE | 582 | ||
| INDICATIONS | 583 | ||
| CRITERIA | 583 | ||
| PREDICTORS OF SUCCESS | 584 | ||
| RISKS | 585 | ||
| CONTRAINDICATIONS | 585 | ||
| PHYSIOLOGY OF UTEROTROPINS AND UTEROTONINS | 585 | ||
| PHARMACOLOGIC METHODS FOR CERVICAL RIPENING: PROSTAGLANDINS E2-DINOPROSTONE | 586 | ||
| PHARMACOLOGIC METHODS FOR CERVICAL RIPENING: PROSTAGLANDIN E1-MISOPROSTOL | 590 | ||
| MECHANICAL METHODS FOR CERVICAL RIPENING: LAMINARIA, SYNTHETIC DILATORS, OR BALLOON CATHETERS | 590 | ||
| BALLOON CATHETERS AND EXTRA-AMNIOTIC SALINE INFUSION | 591 | ||
| PHARMACOLOGIC LABOR INDUCTION METHOD: OXYTOCIN | 593 | ||
| PHYSIOLOGIC METHODS OF LABOR INDUCTION: AMNIOTOMY | 600 | ||
| PHYSIOLOGIC METHODS OF LABOR INDUCTION: STRIPPING OF FETAL MEMBRANES | 602 | ||
| COMPLEMENTARY THERAPIES: BREAST STIMULATION | 602 | ||
| OTHER COMPLEMENTARY THERAPIES | 604 | ||
| CONCLUSION | 605 | ||
| Chapter 29\rDysfunctional Labor | 610 | ||
| INCIDENCE | 610 | ||
| ETIOLOGY | 611 | ||
| NORMAL PHYSIOLOGY | 612 | ||
| PATHOPHYSIOLOGY | 612 | ||
| SIGNS AND SYMPTOMS | 618 | ||
| MATERNAL EFFECTS | 618 | ||
| FETAL AND NEONATAL EFFECTS | 618 | ||
| DIAGNOSTIC TESTING | 619 | ||
| USUAL MEDICAL MANAGEMENT AND PROTOCOLS FOR NURSE PRACTITIONERS | 619 | ||
| NURSING MANAGEMENT | 627 | ||
| CONCLUSION | 650 | ||
| Chapter 30\rProlonged Pregnancy | 660 | ||
| INCIDENCE | 660 | ||
| ETIOLOGY | 660 | ||
| NORMAL PHYSIOLOGY | 661 | ||
| PATHOPHYSIOLOGY | 662 | ||
| SIGNS AND SYMPTOMS | 662 | ||
| MATERNAL EFFECTS | 663 | ||
| FETAL AND NEONATAL EFFECTS | 664 | ||
| DIAGNOSTIC TESTING | 665 | ||
| USUAL MEDICAL MANAGEMENT AND PROTOCOLS FOR NURSE PRACTITIONERS | 666 | ||
| NURSING MANAGEMENT | 667 | ||
| CONCLUSION | 669 | ||
| Index | 671 |